Repaglinide Tablet
Product Images NDC 57237-158

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 57237-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Repaglinide Str)

Chemical structure of Repaglinide, showing its molecular bonds and arrangement of carbon, hydrogen, nitrogen, and oxygen atoms in a complex organic molecule.*

FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)

A line graph showing change in HbA1c (%) over 24 treatment weeks for three groups: Repaglinide + Pioglitazone (solid circles), Repaglinide alone (open circles), and Pioglitazone alone (open squares). The combination group shows a progressive decrease in HbA1c, while the single-agent groups show minimal or no change.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg (100 Tablet Bottle))

Repaglinide Tablets USP 0.5 mg oral tablets packaging label by Rising Pharma Holdings, Inc., containing 100 tablets. The label includes storage instructions, distributor information (Rising Health, LLC, NJ), and a barcode on the right side. It is labeled Rx only and made in India.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg (100 Tablets Carton Label))

Repaglinide Tablets USP 1 mg oral tablet label by Rising Pharma Holdings, Inc. The label indicates a 100-tablet package and notes storage instructions between 20° to 25°C. It includes the NDC 57237-158-01, distributor information for Rising Health, LLC, and states the product is made in India. The label features dosage information, a barcode, and child-resistant closure instructions.*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablets Bottle Label))

Label for Repaglinide Tablets USP 2 mg, oral tablets, packaged as 100 tablets. The label shows the Rising Pharma Holdings, Inc. logo and states the NDC 57237-159-01. It includes storage instructions, dosing reference, and distribution information by Rising Health, LLC in Saddle Brook, NJ. The label also indicates the product is made in India and is for prescription use only.*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablets Carton Label))

Repaglinide Tablets, USP 1 mg oral tablets packaging label from Rising Pharma Holdings, Inc. The label indicates 100 tablets per bottle with the strength prominently displayed as 1 mg. Instructions include storage at 20° to 25°C and keeping the bottle tightly closed with child-resistant closure. The product is distributed by Rising Health, LLC, Saddle Brook, NJ, and made in India.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablets Bottle Label))

Label for Repaglinide Tablets USP 2 mg, oral tablets, containing 100 tablets per bottle. The label shows the Rising Pharma Holdings, Inc. logo and includes storage, dosage, and packaging instructions. It also indicates distribution by Rising Health, LLC, with a revision date of 01/2018 and that the product is made in India. The label features a barcode and space designated as a coding area not to be printed.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablets Carton Label))

Repaglinide Tablets, USP 2 mg oral tablets packaging label by Rising Pharma Holdings, Inc. The label indicates 100 tablets per bottle, storage instructions, and states the product is Rx only. The labeling includes the NDC code 57237-159-01 and distribution details for Rising Health, LLC. The product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.